首页> 外国专利> 12H-DIBENZO d,g 1,3 DIOXOCINE SUBSTITUTED N-HETEROCYCLE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

12H-DIBENZO d,g 1,3 DIOXOCINE SUBSTITUTED N-HETEROCYCLE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

机译:12H-二苯并[d,g] [1,3]二恶英取代的N杂环衍生物,其制备和组成它们的药物成分

摘要

Anti-diabetes mellitus compounds of the formula wherein R1 and R2 independently are hydrogen, halogen, trifluoromethyl, hydroxy, C1-6-alkyl or C1-6-alkoxy; and R3 is hydrogen or C1-3 alkyl; and A is C1-3-alkylene; and Y isOCH-CH2-, LC=CH-, LCH-O-, LC=N-, LN-CH2-, wherein only the underscored atom participates in the ring system; and Z is selected from 3640 כ" ח בשבט התשס" ב - February 10, 2002 wherein n is 1 or 2; and R11 is hydrogen or C1-6-alkyl; and R12 is hydrogen, C1-6-alkyl, C1-6-alkoxy or phenyl optionally substituted with halogen, trifluoromethyl, hydroxy, C1-6-alkyl or C1-6-alkoxy; and R13 is hydrogen, halogen, trifluoromethyl, hydroxy, C1-6-alkyl or C1-6-alkoxy; and R14 is -(CH2)m-OH or -(CH2)tCOR15 wherein m is 0, 1, 2, 3, 4, 5 or 6 and t is 0 or 1 and wherein R15 is -OH, NH2, -NHOH or C1-6-alkoxy; and R16 is C1-6-alkyl or -B-COR15, wherein B is C1-6-alkylene, C2-6-alkenylene or C2-6-alkynylene and R15 is the same as above; and - - - is optionally a single bond or a double bond; or a pharmaceutically acceptable salt thereof, with the proviso that if R1 and R2 independently are hydrogen, halogen or trifluoromethyl and Y is LN-CH2- then R16 cannot be C1-4-alkyl and further that the compound 2-[4-[3-(12H- dibenzo [d,g] [1,3,6] dioxazocin-12-yl)-1- propyl] -piperazin-1-yl]- ethanol is not included.
机译:下式的抗糖尿病化合物:其中R 1和R 2独立地是氢,卤素,三氟甲基,羟基,C 1-6-烷基或C 1-6-烷氧基; R 3为氢或C 1-3烷基; A为C1-3亚烷基; Y为OCH-CH 2-,LC = CH-,LCH-O-,LC = N-,LN-CH 2-,其中只有下划线的原子参与环系统。和Z选自3640- 2002年2月10日,其中n为1或2;和R 11为氢或C 1-6-烷基; R 12是氢,C 1-6-烷基,C 1-6-烷氧基或任选被卤素,三氟甲基,羟基,C 1-6-烷基或C 1-6-烷氧基取代的苯基; R 13为氢,卤素,三氟甲基,羟基,C 1-6-烷基或C 1-6-烷氧基; R14为-(CH2)m-OH或-(CH2)tCOR15,其中m为0、1、2、3、4、5或6,t为0或1,其中R15为-OH,NH2,-NHOH或C 1-6-烷氧基; R 16为C 1-6-烷基或-B-COR 15,其中B为C 1-6-亚烷基,C 2-6-亚烯基或C 2-6-亚炔基,R 15与上述相同。 ---任选地是单键或双键;或其药学上可接受的盐,条件是如果R1和R2独立地是氢,卤素或三氟甲基,Y是LN-CH2-,则R16不能是C1-4-烷基,并且化合物2- [4- [3 -(12H-二苯并[d,g] [1,3,6]二恶唑啉-12-基)-1-丙基]-哌嗪-1-基]-乙醇不包括在内。

著录项

  • 公开/公告号IL123424B

    专利类型

  • 公开/公告日2002-02-10

    原文格式PDF

  • 申请/专利权人 NOVO NORDISK A/S;

    申请/专利号IL123424

  • 发明设计人

    申请日1998-02-24

  • 分类号

  • 国家 IL

  • 入库时间 2022-08-22 00:45:01

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号